Literature DB >> 26720272

Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy.

Zhi Ven Fong1, Matthew T McMillan2, Giovanni Marchegiani3, Klaus Sahora1, Giuseppe Malleo3, Matteo De Pastena3, Andrew P Loehrer1, Grace C Lee1, Cristina R Ferrone1, David C Chang1, Matthew M Hutter1, Jeffrey A Drebin2, Claudio Bassi3, Keith D Lillemoe1, Charles M Vollmer2, Carlos Fernández-Del Castillo1.   

Abstract

IMPORTANCE: Wound infections after pancreaticoduodenectomy (PD) are common. The standard antibiotic prophylaxis given to prevent the infections is often a cephalosporin. However, this decision is rarely guided by microbiology data pertinent to PD, particularly in patients with biliary stents.
OBJECTIVE: To analyze the microbiology of post-PD wound infection cultures and the effectiveness of institution-based perioperative antibiotic protocols. DESIGN, SETTING, AND PARTICIPANTS: The pancreatic resection databases of 3 institutions (designated as institutions A, B, or C) were queried on patients undergoing PD from June 1, 2008, to June 1, 2013, and a total of 1623 patients were identified. Perioperative variables as well as microbiology data for intraoperative bile and postoperative wound cultures were analyzed from June 1, 2008, to June 1, 2013.
INTERVENTIONS: Perioperative antibiotic administration. MAIN OUTCOMES AND MEASURES: Wound infection microbiology analysis and resistance patterns.
RESULTS: Of the 1623 patients who underwent PD, 133 with wound infections (8.2%) were identified. The wound infection rate did not differ significantly across the 3 institutions. The predominant perioperative antibiotics used at institutions A, B, and C were cefoxitin sodium, cefazolin sodium with metronidazole, and ampicillin sodium-sulbactam sodium, respectively. Of the 133 wound infections, 89 (67.1%) were deep-tissue infection, occurring at a median of 8 (range, 1-57) days after PD. A total of 53 (40.0%) of the wound infections required home visiting nurse services on discharge, and 73 (29.1%) of all PD readmissions were attributed to wound infection. Preoperative biliary stenting was the strongest predictor of postoperative wound infection (odds ratio, 2.5; 95% CI, 1.58-3.88; P = .03). There was marked institutional variation in the type of microorganisms cultured from both the intraoperative bile and wound infection cultures (Streptococcus pneumoniae, 114 cultures [47.9%] in institution A vs 3 [4.5%] in institution B; P = .001) and wound infection cultures (predominant microorganism in institution A: Enterococcus faecalis, 18 cultures [51.4%]; institution B: Staphylococcus aureus, 8 [43.9%]; and institution C: Escherichia coli, 17 [36.2%], P = .001). Similarly, antibiotic resistance patterns varied (resistance pattern in institution A: cefoxitin, 29 cultures [53.1%]; institution B: ampicillin-sulbactam, 9 [69.2%]; and institution C: penicillin, 32 [72.7%], P < .001). Microorganisms isolated in intraoperative bile cultures were similar to those identified in wound cultures in patients with post-PD wound infections. CONCLUSIONS AND RELEVANCE: The findings of this large-scale, multi-institutional study indicate that intraoperative bile cultures should be routinely obtained in patients who underwent preoperative endoscopic retrograde cholangiopancreatography since the isolated microorganisms closely correlate with those identified on postoperative wound cultures. Institution-specific internal reviews should amend current protocols for antibiotic prophylaxis to reduce the incidence of wound infections following PD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26720272     DOI: 10.1001/jamasurg.2015.4510

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  16 in total

Review 1.  Effectiveness and risk of biliary drainage prior to pancreatoduodenectomy: review of current status.

Authors:  Alban Zarzavadjian Le Bian; David Fuks; Raffaele Dalla Valle; Manuela Cesaretti; Vincenzo Violi; Renato Costi
Journal:  Surg Today       Date:  2017-07-13       Impact factor: 2.549

2.  The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.

Authors:  Kimitaka Tanaka; Toru Nakamura; Shungo Imai; Hiroki Kushiya; Daisuke Miyasaka; Yoshitsugu Nakanishi; Toshimichi Asano; Takehiro Noji; Takahiro Tsuchikawa; Keisuke Okamura; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surg Today       Date:  2018-04-23       Impact factor: 2.549

3.  Unmet needs in preoperative biliary stenting for patient candidates for pancreaticoduodenectomy: a viewpoint.

Authors:  Salvatore Paiella; Matteo De Pastena; Roberto Salvia
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

Review 4.  Prognostic Impact of Bacterobilia on Morbidity and Postoperative Management After Pancreatoduodenectomy: A Systematic Review and Meta-analysis.

Authors:  Benjamin Müssle; Sebastian Hempel; Christoph Kahlert; Marius Distler; Jürgen Weitz; Thilo Welsch
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

5.  Unique predictors and economic burden of superficial and deep/organ space surgical site infections following pancreatectomy.

Authors:  Ayòtúndé B Fadayomi; Gyulnara G Kasumova; Omidreza Tabatabaie; Susanna W L de Geus; Tara S Kent; Sing Chau Ng; A James Moser; Mark P Callery; Stanley W Ashley; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2018-03-09       Impact factor: 3.647

6.  Surgical Antibiotic Prophylaxis and Risk for Postoperative Antibiotic-Resistant Infections.

Authors:  Margot E Cohen; Hojjat Salmasian; Jianhua Li; Jianfang Liu; Philip Zachariah; Jason D Wright; Daniel E Freedberg
Journal:  J Am Coll Surg       Date:  2017-10-10       Impact factor: 6.113

7.  Poor Results of Pancreatoduodenectomy in High-Risk Patients with Endoscopic Stent and Bile Colonization are Associated with E. coli, Diabetes and Advanced Age.

Authors:  Renato Costi; Matteo De Pastena; Giuseppe Malleo; Giovanni Marchegiani; Giovanni Butturini; Vincenzo Violi; Roberto Salvia; Claudio Bassi
Journal:  J Gastrointest Surg       Date:  2016-05-11       Impact factor: 3.452

8.  Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer.

Authors:  Luca Gianotti; Nicolò Tamini; Francesca Gavazzi; Anna Mariani; Marta Sandini; Fabio Ferla; Marco Cereda; Giovanni Capretti; Stefano Di Sandro; Davide Paolo Bernasconi; Luciano De Carlis; Alessandro Zerbi
Journal:  J Gastrointest Surg       Date:  2017-07-05       Impact factor: 3.452

Review 9.  A NSQIP-based randomized clinical trial evaluating choice of prophylactic antibiotics for pancreaticoduodenectomy.

Authors:  Brian C Brajcich; Clifford Y Ko; Jason B Liu; Ryan J Ellis; Michael I D Angelica
Journal:  J Surg Oncol       Date:  2021-05       Impact factor: 3.454

10.  Pancreatoduodenectomy within 2 weeks after endoscopic retrograde cholangio-pancreatography increases the risk of organ/space surgical site infections: a 5-year retrospective cohort study in a high-volume centre.

Authors:  Wensen Chen; Kai Zhang; Zhongheng Zhang; Zipeng Lu; Daoquan Zhang; Juan Liu; Yue Yang; Yinzhi Leng; Yongxiang Zhang; Weihong Zhang; Kuirong Jiang; Guihua Zhuang; Yi Miao; Yun Liu
Journal:  Gland Surg       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.